Search by keyword:

Show results   

Recent headlines

Reuters

More headlines
  • Clot-busting drug ups bleeding stroke survival   NEW YORK (Reuters Health) - New research confirms that a very low dose of tissue plasminogen activator (tPA), a clot-busting drug, improves survival in patients with bleeding or "hemorrhagic" strokes, a type that is usually fatal.
  • Research links common chemicals to obesity  GENEVA (Reuters) - Exposure in the womb to common chemicals used to make everything from plastic bottles to pizza box liners may program a person to become obese later in life, U.S. researchers said on Wednesday.
  • Health ministers to debate drug patent dispute  GENEVA (Reuters) - Health ministers from around the world will try next week to bridge differences over how to overhaul drug patent rules that developing countries say make life-saving medicines costly and inaccessible.
  • Drug adherence does not explain diabetes race gap  NEW YORK (Reuters Health) - Differences in medication adherence do not fully explain why African Americans fare more poorly than whites in managing their diabetes, a new study suggests.
  • Bird flu pandemic will need multiple drugs   LONDON (Reuters) - Governments need to stockpile different sorts of flu drugs - not just Roche Holding AG's Tamiflu - to counter the danger of resistance in a pandemic triggered by bird flu, British experts said on Wednesday.
      More headlines


    About Our Sutter Health Network   ·   Contact Us   ·   Privacy Policy   ·   Home